优化COVID-19的临床管理:未接种疫苗的患者进入ICU的预测模型
Ahmed Farhan1, Khouloud Ayed1, Sara Zayati1
1Laboratory of Genetics, Immunology, and Human Pathologies, Faculty of Sciences of Tunis, University Tunis El Manar, Tunis 2092, Tunisia.
Pathogens (Basel, Switzerland)
|March 26, 2025
概括
对于未接种疫苗的COVID-19患者来说,晚年,并发症和高炎性细胞因子 (如IL-6和TNF-α) 会增加严重的结果. 低IgG抗体水平表明住院时间较长,恢复速度较慢.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 关键护理医学 关键护理医学
背景情况:
- COVID-19带来了重大风险,特别是在未接种疫苗的人群中.
- 了解影响COVID-19严重程度的因素对于患者管理至关重要.
研究的目的:
- 在未接种疫苗的ICU患者中调查COVID-19结果的免疫学和临床预测因素.
- 评估年龄,并发症,细胞因子 (IL-6,TNF-α) 和IgG水平对患者预后的影响.
主要方法:
- 对42名未接种疫苗的ICU患者的分析.
- 评估临床数据 (年龄,并发症) 和免疫标记 (IL-6,TNF-α,抗SARS-CoV-2 IgG).
- 评估结果,包括住院,康复,并发症和死亡率.
主要成果:
- 晚年,心血管疾病和IL-6/TNF-α升高与增加的并发症和死亡率有关.
- 较低的IgG抗体水平与长时间住院和延迟康复相关.
- 高IL-6和TNF-α被确定为不利的COVID-19结果的强有力的预测因素.
结论:
- 早期监测细胞因子和有针对性的干预措施对于管理高风险的未接种疫苗的COVID-19患者至关重要.
- 免疫学标记在确定COVID-19的严重程度和预后方面发挥着重要作用.
相关概念视频
Pneumonia IV: Management
280
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
280
Pneumonia V: Nursing management and Prevention
1.8K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.8K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
163
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
163
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance
51
Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
51
Methods of Documentation VI: Case Management Model
548
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
548


